Subtype
Esophageal Carcinoma
CI-CAN-00002609ESCAExplore in graph →
307 active trials4 approved drugs11 evidence items
- NCIt
- C3513
- DOID
- 1107
- Other
- 1 more code
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00002609ESCAExplore in graph →
Clinical trials
807 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (62)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01831531 | Study of S-1 in Combination With Radiotherapy in Esophageal Cancer | completed | Phase 2 | 105 | Fudan UniversityOTHER | 1 | Feb 15, 2019 | clinicaltrials |
| NCT01262040 | Narrow Band Imaging (NBI): A Novel Imaging Modality in Minimally Invasive | completed | N/A | 154 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Nov 7, 2018 | clinicaltrials |
| A Phase III Study of Comparing Paclitaxel Plus 5-Fluorouracil Versus Cisplatin Plus 5-Fluorouracil in Chemoradiotherapy for Locally Advanced Esophageal Carcinoma |
| completed |
| Phase 3 |
| 436 |
| Fudan UniversityOTHER |
| 1 |
| Oct 18, 2018 |
| clinicaltrials |
| NCT01561014 | Oxaliplatin, Fluorouracil, Erlotinib Hydrochloride, and Radiation Therapy Before Surgery and Erlotinib Hydrochloride After Surgery in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction | completed | Phase 1 | 9 | Wake Forest University Health SciencesOTHER | 1 | Jul 2, 2018 | clinicaltrials |
| NCT02435602 | The Role of Chromoendoscopy in the Early Detection of Esophageal Cancer in Patients With Prior Head and Neck Cancers | completed | N/A | 294 | Maria Sklodowska-Curie National Research Institute of OncologyOTHER | 1 | Apr 13, 2018 | clinicaltrials |
| NCT01612546 | Pilot Trial of CRLX101 in Treatment of Patients With Advanced or Metastatic Stomach, Gastroesophageal, or Esophageal Cancer That Cannot be Removed by Surgery | completed | Phase 2 | 10 | City of Hope Medical CenterOTHER | 1 | Feb 1, 2018 | clinicaltrials |
| NCT01097304 | Ursodiol in Treating Patients With Barrett Esophagus and Low-Grade Dysplasia | completed | Phase 2 | 36 | National Cancer Institute (NCI)NIH | 1 | Dec 19, 2017 | clinicaltrials |
| NCT01178944 | Pralatrexate and Oxaliplatin in Treating Patients With Unresectable or Metastatic Esophageal, Stomach, or Gastroesophageal Junction Cancer | completed | Phase 2 | 35 | Roswell Park Cancer InstituteOTHER | 1 | Dec 13, 2017 | clinicaltrials |
| NCT01551589 | Involved Field Irradiation (IFI) Versus Elective Nodal Irradiation (ENI) for Esophageal Cancer | completed | N/A | 220 | Chengya ChouOTHER | 1 | Jul 26, 2017 | clinicaltrials |
| NCT01807546 | Oral Rigosertib for Squamous Cell Carcinoma | completed | Phase 2 | 64 | Traws Pharma, Inc.INDUSTRY | 1 | Jun 26, 2017 | clinicaltrials |
| NCT01231399 | Everolimus and Combination Chemotherapy in Treating Patients With Metastatic Stomach or Esophageal Cancer | completed | Phase 1 / Phase 2 | 6 | City of Hope Medical CenterOTHER | 1 | May 31, 2017 | clinicaltrials |
| NCT02100189 | Esophageal Cytology With FISH in Detecting Esophageal Cancer | completed | N/A | 50 | OHSU Knight Cancer InstituteOTHER | 1 | May 11, 2017 | clinicaltrials |
| NCT02610764 | Pilot Sudy: Resectable Esophageal Adenocarcinoma and the Relevance of CTC(ESO-CTC) | completed | N/A | 19 | University Hospital FreiburgOTHER | 1 | Apr 13, 2017 | clinicaltrials |
| NCT02075905 | Stratifying Risk in Barrett's Esophagus: A Pilot Study for Biomarker-based Patient Management | completed | — | 111 | University of North Carolina, Chapel HillOTHER | 3 | Dec 20, 2016 | clinicaltrials |
| NCT01522820 | Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors | completed | Phase 1 | 18 | Roswell Park Cancer InstituteOTHER | 1 | Oct 4, 2016 | clinicaltrials |
| NCT01608022 | A Phase II Trial of PF-00299804 in Patients With Metastatic or Recurrent Squamous Cell Carcinoma of Esophagus | completed | Phase 2 | 48 | Yonsei UniversityOTHER | 1 | Sep 7, 2016 | clinicaltrials |
| NCT00176800 | Chemoradiation and Tetrathiomolybdate (TM) in Patients With Esophageal Carcinoma | completed | Phase 2 | 69 | University of Michigan Rogel Cancer CenterOTHER | 1 | Aug 22, 2016 | clinicaltrials |
| NCT02861690 | Liposomal Paclitaxel Combined Nedaplatin in Treatment of Advanced or Recurrent Esophageal Carcinoma | completed | Phase 2 | 72 | Sun Yat-sen UniversityOTHER | 1 | Aug 10, 2016 | clinicaltrials |
| NCT01129206 | Pralatrexate and Docetaxel in Treating Patients With Stage IV Esophageal or Gastroesophageal Cancer Who Have Failed Platinum-Based Therapy | completed | Phase 2 | 6 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Jun 1, 2016 | clinicaltrials |
| NCT01854749 | S1 Combined With Cisplatin in Treatment of Recurrence/Metastasis of ESCC Open-label Single Center Phase II Clinical Study | completed | Phase 2 | 57 | Fudan UniversityOTHER | 1 | Feb 23, 2016 | clinicaltrials |
| NCT00590031 | Phase II Trial of Preoperative Combined Modality Therapy for Esophageal Carcinoma: Cisplatin-Irinotecan Followed by Radiation Therapy With Concurrent Cisplatin and Irinotecan. | completed | Phase 2 | 61 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 25, 2016 | clinicaltrials |
| NCT00586989 | Endoscopic Tri-Modal Imaging in Patients With Barrett's Esophagus(ETMI) | completed | — | 60 | Mayo ClinicOTHER | 2 | Jan 7, 2016 | clinicaltrials |
| NCT01469598 | Study of Docetaxel and Gemcitabine in Metastatic Esophageal Squamous Cell Cancer | completed | Phase 2 | 24 | Samsung Medical CenterOTHER | 1 | Dec 29, 2015 | clinicaltrials |
| NCT01474642 | Phase II Trial of XP Versus XG in Advanced Esophageal Squamous Cell Carcinoma | completed | Phase 2 | 64 | Samsung Medical CenterOTHER | 1 | Dec 29, 2015 | clinicaltrials |
| NCT01932580 | Pilot Study of Perioperative Docetaxel, Oxaliplatin, and 5-Fluorouracil (FLOT) in Gastroesophageal Adenocarcinoma | completed | Phase 2 | 10 | McGill UniversityOTHER | 1 | Oct 27, 2015 | clinicaltrials |
| NCT01871636 | ESD Versus EMR for Treatment of Early Barrett's Adenocarcinoma | completed | N/A | 40 | Evangelisches Krankenhaus DüsseldorfOTHER | 1 | Sep 9, 2015 | clinicaltrials |
| NCT00909350 | Micro-RNA (miR) Expression in Upper Gastrointestinal Mucosal Tissue | completed | — | 10 | Mayo ClinicOTHER | 1 | Feb 12, 2015 | clinicaltrials |
| NCT00165490 | Combination Chemotherapy, Radiation Therapy and Surgery for Esophageal Cancer | completed | Phase 2 | 19 | Dana-Farber Cancer InstituteOTHER | 1 | Nov 10, 2014 | clinicaltrials |
| NCT01258192 | Neoadjuvant Chemotherapy With Nab-paclitaxel Plus Cisplatin for Stage Ⅱ-Ⅲ Esophageal Cancer Patients(nabPCESCC) | completed | Phase 2 | 35 | Zhejiang Cancer HospitalOTHER | 1 | Jul 29, 2014 | clinicaltrials |
| NCT02094105 | Endoscopic Screening on Esophageal Cancer | completed | N/A | 45,386 | Chinese Academy of Medical SciencesOTHER | 1 | Mar 21, 2014 | clinicaltrials |
| NCT00077545 | 3-AP Plus Cisplatin in Treating Patients With Recurrent or Metastatic Adenocarcinoma of the Esophagus or Gastroesophageal Junction | completed | Phase 2 | 39 | National Cancer Institute (NCI)NIH | 1 | Oct 8, 2013 | clinicaltrials |
| NCT00045526 | Erlotinib Hydrochloride in Treating Patients With Advanced Esophageal Cancer or Stomach Cancer | completed | Phase 2 | 48 | National Cancer Institute (NCI)NIH | 1 | Jun 4, 2013 | clinicaltrials |
| NCT01472419 | Prognostic Factor Analysis in Metastatic Esophageal Squamous Cell Carcinoma | completed | — | 239 | Samsung Medical CenterOTHER | 0 | Apr 9, 2013 | clinicaltrials |
| NCT00733889 | A Study to Evaluate the Combination of Cetuximab and Chemotherapy as Neoadjuvant Therapy Followed Concomitant Chemoradiotherapy Plus Cetuximab in Locoregional Esophageal Carcinoma | completed | Phase 2 | 50 | Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)OTHER | 1 | Feb 20, 2013 | clinicaltrials |
| NCT01391208 | Esophageal Protocol for Detection of Neoplasia in the Digestive Tract | completed | Phase 1 | 25 | University of MichiganOTHER | 1 | Oct 11, 2012 | clinicaltrials |
| NCT01605305 | Study on FOLFOX6 as First-line Therapy to Treat Recurrent or Metastatic Esophageal Cancer | completed | Phase 2 | 60 | Fudan UniversityOTHER | 0 | May 24, 2012 | clinicaltrials |
| NCT01269970 | Early Metabolic Response in Locally Advanced Esophageal Cancer Undergoing Induction Chemoradiotherapy | completed | — | — | Universitaire Ziekenhuizen KU LeuvenOTHER | 1 | Jan 4, 2011 | clinicaltrials |
| NCT00423254 | Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer. | completed | Phase 1 | 12 | Mannkind CorporationINDUSTRY | 1 | Aug 3, 2010 | clinicaltrials |
| NCT00165191 | Doxorubicin, Cisplatin, 5-Fluorouracil in Patients With Advanced Adenocarcinoma of the Stomach or Esophagus | completed | Phase 2 | 32 | Dana-Farber Cancer InstituteOTHER | 1 | Apr 28, 2009 | clinicaltrials |
Data updated 22 days agoSource updated Feb 15, 2019source: clinicaltrials